A Study of Hydrogen Peroxide-Generating E-bandage Safety
Launched by MAYO CLINIC · Jul 3, 2023
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of bandage that generates hydrogen peroxide, which is known for its ability to help prevent infections and promote healing in wounds. The researchers want to see if these special bandages are safe to use on healthy skin and that they don’t cause any harmful effects.
To be eligible for this trial, participants should be healthy adults aged between 65 and 74, with no skin problems and intact skin on their arms. They'll need to be able to give their consent to join the study. During the trial, participants will wear the e-bandage, and the researchers will monitor their skin to ensure there are no negative reactions. It's important to note that pregnant individuals, children, and anyone with skin diseases or injuries will not be able to participate. Overall, this study will help us understand if this innovative bandage could be a safe option for wound care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy.
- • Intact skin on arms.
- • Able to provide appropriate consent.
- Exclusion Criteria:
- • Vulnerable study population.
- • Pregnancy.
- • Children.
- • Skin disease.
- • Non-intact skin on arms.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Robin Patel, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported